Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from RE-COVER(®), RE-COVER™ II, and RE-MEDY™

por Feuring, Martin, Schulman, Sam, Eriksson, Henry, Kakkar, Ajay J., Schellong, Sebastian, Hantel, Stefan, Schueler, Elke, Kreuzer, Jörg, Goldhaber, Samuel Z.
Publicado 2017

Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure: A Secondary Analysis of EMPEROR-Pooled

por Ferreira, João Pedro, Zannad, Faiez, Butler, Javed, Filippatos, Gerasimos, Pocock, Stuart J., Brueckmann, Martina, Steubl, Dominik, Schueler, Elke, Anker, Stefan D., Packer, Milton
Publicado 2022